Healthcare -
Biotechnology - NASDAQ - US
$ 37.67
0.106 %
$ 3 B
Market Cap
-10.05
P/E
AKRO - CASH FROM OPERATIONS
Cash from Operations AKRO - Akero Therapeutics, Inc.
-230 M
LAST VALUE
-57.71%
2 YEAR CAGR
-45.22%
5 YEAR CAGR
0.00%
10 YEAR CAGR